Screener
Tarsus Pharmaceuticals, Inc. TARS Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 43,271,347 shares issued and outstanding at June 30, 2026 (unaudited); 42,553,931 shares issued and outstanding at December 31, 2025 | 6 | 6 |
| Additional paid-in capital | 799,429 | 769,667 |
| Accumulated other comprehensive income (loss) | (557) | 381 |
| Accumulated deficit | (452,146) | (426,628) |
| Total stockholders’ equity | 346,732 | 343,426 |
| Total liabilities and stockholders’ equity | $611,142 | $562,158 |
Item 1. Financial Statements
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s total liabilities & equity?
- Tarsus Pharmaceuticals, Inc. (TARS) reported total liabilities & equity of $611.14M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s total liabilities & equity changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s total liabilities & equity increased by 23.5% year-over-year, from $494.99M to $611.14M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s total liabilities & equity has grown at a 26.7% compound annual growth rate (CAGR), from $171.97M to $562.16M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude